Alyssa Klein

1.4k total citations · 1 hit paper
28 papers, 754 citations indexed

About

Alyssa Klein is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Alyssa Klein has authored 28 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Alyssa Klein's work include Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Alyssa Klein is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Alyssa Klein collaborates with scholars based in United States, United Kingdom and Germany. Alyssa Klein's co-authors include Ion Cotarla, Apar Kishor Ganti, Engels Chou, Brian Seal, Beth Nordstrom, Jason C. Simeone, Ketan Patel, Robert Morlock, Natalia M. Flores and Scott Baumgartner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Alyssa Klein

26 papers receiving 743 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

2021 387 citations Apar Kishor Ganti, Alyssa Klein et al. JAMA Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alyssa Klein United States	11	372	331	180	155	106	28	754
Marija Bojić Austria	10	350 0.9×	364 1.1×	283 1.6×	83 0.5×	57 0.5×	39	948
Wen Cai China	16	209 0.6×	262 0.8×	122 0.7×	89 0.6×	33 0.3×	55	565
Yasunobu Hashimoto Japan	20	630 1.7×	265 0.8×	283 1.6×	563 3.6×	65 0.6×	84	1.2k
Marina D. Kaymakcalan United States	15	374 1.0×	423 1.3×	261 1.4×	165 1.1×	17 0.2×	32	912
Ketki Tendulkar United States	13	265 0.7×	345 1.0×	167 0.9×	47 0.3×	36 0.3×	22	645
E. del Barco Spain	17	260 0.7×	341 1.0×	145 0.8×	95 0.6×	18 0.2×	66	629
Hironori Fukuda Japan	15	566 1.5×	449 1.4×	211 1.2×	218 1.4×	25 0.2×	96	788
Masayuki Hagiwara Japan	17	265 0.7×	299 0.9×	311 1.7×	280 1.8×	24 0.2×	58	819
Stefano Battaglia Italy	12	277 0.7×	123 0.4×	264 1.5×	88 0.6×	31 0.3×	18	603
L. Leong United States	16	241 0.6×	648 2.0×	199 1.1×	238 1.5×	27 0.3×	41	1.0k

Countries citing papers authored by Alyssa Klein

Since Specialization

Citations

This map shows the geographic impact of Alyssa Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alyssa Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alyssa Klein more than expected).

Fields of papers citing papers by Alyssa Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alyssa Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alyssa Klein. The network helps show where Alyssa Klein may publish in the future.

Co-authorship network of co-authors of Alyssa Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Alyssa Klein. A scholar is included among the top collaborators of Alyssa Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alyssa Klein. Alyssa Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iyer, Renuka, Kathryn Evans, Alyssa Klein, et al.. (2025). Real-world assessment of MDM2 amplification and survival among patients with advanced or metastatic biliary tract cancer in the United States.. Journal of Clinical Oncology. 43(4_suppl). 544–544. 1 indexed citations

Klein, Alyssa, William J. Ennis, & Eri Fukaya. (2022). Characteristics of venous leg ulcer patients at a tertiary wound care center. Journal of Vascular Surgery Venous and Lymphatic Disorders. 11(2). 270–279.e1. 4 indexed citations

Fukaya, Eri, Alyssa Klein, Judy M. Lau, & Elizabeth V Ratchford. (2022). Vascular Disease Patient Information Page: Venous leg ulcers. Vascular Medicine. 28(1). 89–92.

Ganti, Apar Kishor, Alyssa Klein, Ion Cotarla, Brian Seal, & Engels Chou. (2021). Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US. JAMA Oncology. 7(12). 1824–1824. 387 indexed citations breakdown →

Klein, Alyssa, et al.. (2020). Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart. Journal of Visualized Experiments. 3 indexed citations

Klein, Alyssa, et al.. (2020). Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart. Journal of Visualized Experiments. 8 indexed citations

Shire, Norah J., Alyssa Klein, Asieh Golozar, et al.. (2020). STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world. PLoS ONE. 15(9). e0238358–e0238358. 54 indexed citations

Girard, Nicolas, Rainer Fietkau, Marina Chiara Garassino, et al.. (2020). 1242P Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy. Annals of Oncology. 31. S805–S806. 2 indexed citations

Nordstrom, Beth, et al.. (2020). Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparison. Journal of Comparative Effectiveness Research. 9(3). 191–199. 3 indexed citations

10.

Jaffe, Dena H., Alyssa Klein, Arriel Benis, et al.. (2019). Incident gout and chronic Kidney Disease: healthcare utilization and survival. BMC Rheumatology. 3(1). 11–11. 18 indexed citations

11.

Stack, Austin G., Betina T. Blak, Alyssa Klein, et al.. (2019). Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study. BMJ Open. 9(8). e031550–e031550. 30 indexed citations

12.

Klein, Alyssa, Rohan Parikh, Samantha K. Kurosky, Elizabeth Esterberg, & James A. Kaye. (2019). PCN311 CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA AFTER PROGRESSION ON PLATINUM-BASED THERAPY: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA. Value in Health. 22. S115–S115. 1 indexed citations

13.

Agarwal, Rajni, Christopher C. Dvorak, Hye‐Sook Kwon, et al.. (2019). Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency. Blood. 134(Supplement_1). 800–800. 19 indexed citations

14.

Simeone, Jason C., Beth Nordstrom, Ketan M. Patel, et al.. (2019). Treatment patterns and overall survival in metastatic urothelial carcinoma in a real-world, US setting. Cancer Epidemiology. 60. 121–127. 30 indexed citations

15.

Simeone, Jason C., Beth Nordstrom, Ketan Patel, & Alyssa Klein. (2019). Treatment Patterns and Overall Survival in Metastatic Non-Small-Cell Lung Cancer in a Real-World, US Setting. Future Oncology. 15(30). 3491–3502. 90 indexed citations

16.

Girard, Nicolas, F. Mornex, Daniel C. Christoph, et al.. (2019). PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy. Annals of Oncology. 30. ii37–ii37. 9 indexed citations

17.

Hoyle, Christopher, Alyssa Klein, Norah J. Shire, et al.. (2018). Match-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy. Annals of Oncology. 29. viii323–viii323. 1 indexed citations

18.

Klein, Alyssa, et al.. (2018). Designing and Optimizing Digital Applications for Medical Emergencies. PubMed. 2018. 1–6. 3 indexed citations

19.

Pagidipati, Neha J., Connie N. Hess, Robert M. Clare, et al.. (2017). An examination of the relationship between serum uric acid level, a clinical history of gout, and cardiovascular outcomes among patients with acute coronary syndrome. American Heart Journal. 187. 53–61. 30 indexed citations

20.

Pillinger, Michael H., Sripal Bangalore, Alyssa Klein, Scott Baumgartner, & Robert Morlock. (2017). Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization. Journal of Managed Care & Specialty Pharmacy. 23(6). 677–683. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact